Branford, CT, United States of America

Xu Kevin Lin




Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Brandford, CT (US) (2005)
  • Branford, CT (US) (2002 - 2014)

Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Xu Kevin Lin: Innovator in Pharmaceutical Compounds

Introduction

Xu Kevin Lin is a notable inventor based in Branford, Connecticut, with a significant contribution to the field of pharmaceuticals. He holds a total of six patents, showcasing his innovative approach to developing compounds that address various medical conditions.

Latest Patents

Among his latest patents is the invention of Pyridyl-2-methylamino compounds, compositions, and their uses. These compounds are designed to prevent and treat a variety of conditions in mammals, including Alzheimer's Disease, Down's syndrome, and Parkinson's Disease. Another significant patent is the process for synthesizing the anti-neoplasia agent VNP40101M. This invention outlines simple, safe, and high-yield methods for synthesizing VNP40101M, which is crucial in cancer treatment.

Career Highlights

Xu Kevin Lin has worked with prominent companies in the pharmaceutical industry, including Vion Pharmaceuticals, Inc. and Aria Neurosciences Inc. His work has significantly impacted the development of therapeutic agents, particularly in the realm of neurodegenerative diseases and cancer.

Collaborations

Throughout his career, Xu has collaborated with esteemed colleagues such as Ivan C. King and Terrence W. Doyle, contributing to the advancement of innovative pharmaceutical solutions.

Conclusion

Xu Kevin Lin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…